Hemp, Inc. (OTC PINK: HEMP) announced today that its farming associates, who are licensed in the state of North Carolina by the NC Industrial Hemp Commission, have secured 150+ pounds of CBD-rich hemp seeds which are to be planted this weekend and/or next week. According to CEO Bruce Perlowin, the 150+ pounds of seeds equate to over 550 acres to go along with the 17 acres of high-CBD clones they are planting in North Carolina and Colorado. It will be one of, or, the largest CBD hemp grows in the United States to date.
The company also plans on purchasing its second CBD Extractor this year. As announced in Hemp, Inc.'s last press release, the company has already purchased its first industrial NuAxon Tech CO2 Supercritical extractor from NuAxon BioScience, the manufacturer and producer of the world class, large capacity CO2 Supercritical Extraction equipment. However, with the industry's expanding CBD market and ever-increasing consumer CBD sales over the past few years, executives feel it is in the best interest of its shareholders to acquire a second extractor to capture a solid, sizeable share of the market while still in the early growth stage.
The CBD market is expected to "grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources. That's a 700% increase from 2016. In 2015, the market for consumer sales of hemp-derived CBD products was $90 million, plus another $112 million in marijuana-derived CBD products which were sold through dispensaries -- bringing a total CBD market to $202 million last year," according to Forbes.com.
David Schmitt, COO of Hemp, Inc.'s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM), said they have been researching CBD extraction methods and manufacturers for the past 2 years, weighing the pros and cons of both. For its second CBD extractor purchase, executives found another manufacturer they feel would produce another superior CBD extractor that utilizes a different technology. Based on Hemp, Inc.'s research, building a CBD extractor takes extensive testing, product knowledge and continual process improvement to ensure a superior product that is held to the highest of standards. A collaborative design engineering team that ensures the quality of each component, coupled with a customizable approach, guarantees the extractor will meet all of Hemp, Inc.'s specifications and standards.
Schmitt expects both extractors to have optimized production levels. "The CO2 Supercritical Extractor that is currently in-house is expected to be assembled over the next 3 months. Once assembled, we will be ready to process and extract CBD oil," said Schmitt.
Bruce Perlowin, CEO of Hemp, Inc. (OTC PINK: HEMP) said, "The CBD market has been growing by leaps and bounds. CBD's medicinal qualities have been making waves across America. Residents in states that have not legalized medical marijuana are finding that CBDs from hemp are an alternative to pharmaceutical drugs to treat debilitating medical conditions. There have been recent studies showing CBDs are preferred over addicting pharmaceutical drugs."
Earlier this year, the National Academies of Science, Engineering, and Medicine (NASEM) released a comprehensive report regarding cannabis' health benefits. The study confirmed substantial evidence that cannabis is useful in the treatment of some common and severe medical ailments such as chronic pain, multiple sclerosis, and chemotherapy-induced nausea and vomiting. It was also interesting to note that pharmaceutical companies have started creating cannabis-like drugs for multiple sclerosis, nausea and vomiting. While the pharmaceutical alternative, CBD, is viewed as a more appealing option, it is often expensive and not readily available to patients.
The pharmaceutical choices, such as prescribed opioid pain medications, are addictive and users are at high risk of fatal overdose.
Cannabidiol (CBD) is the part of the cannabis plant that has significant medical benefits, but does not make people feel "high" and can even counteract the psychoactivity of THC (that part that does make people feel "high"). Since CBDs are non-psychoactive, it's an appealing option for medical patients seeking alternative ways to relieve conditions such as inflammation, pain, anxiety, psychosis, seizures, and spasms, without disconcerting feelings of lethargy.
According to ProjectCBD, "Scientific and clinical research -- much of it sponsored by the US government -- underscores CBD's potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere."
"With two commercial, superior quality and efficient CBD extractors, Hemp, Inc. will have a huge advantage in the marketplace and will have positioned itself to be known for using the best method for extracting the therapeutic compounds needed to treat debilitating medical conditions. Our goal is to be able to deliver safe, pure and potent CBD oils and drive the price of CBDs down to a level where every American family can afford them, since according to science, everyone in America is CBD deficient," said Perlowin.
This extractor that is currently in-house will be showcased during the upcoming Hemp University educational symposium that will focus on the Art and Science of CBD Greenhouse Growing. Per Perlowin, this is only the beginning of building the extraction infrastructure to serve the industrial hemp industry.
According to Headset Research data, in Washington state alone there are over 800 CBD products in the marketplace. However, it's difficult for consumers to know how pure or how potent the CBD product is and, unfortunately, the Federal Drug Administration (FDA) disallows medical claims to be made which makes it difficult for consumers to know what to buy.
"Right now, consumers have to stay abreast of the research. For instance, cannabidiol can help with Dravet syndrome, which is a very rare condition caused by a genetic mutation," said Perlowin. The research Perlowin is referring to was conducted by Dr. Devinsky, who, with his team, treated over 100 children who Dravet syndrome with cannabidiol. According to the source, in the study, "half of the children were given a CBD supplement, while the remainder were given the placebo. The researchers found that the CBD group exhibited a staggering 39 percent reduction in seizure frequency -- and five percent of the patients stopped having seizures altogether. As the team explained i n their research, which was published in the New England Journal of Medicine, patients in the trial who took CBD went from having an average of 12 seizures per month to about six." See the NaturalNews.com article.
Another study, conducted by the University of Wollongong (in Australia), found that "an active compound in cannabis [cannabidiol] could help improve some of the negative and drug resistant symptoms of schizophrenia." Schizophrenia is a debilitating mental illness that ranks among the top 10 causes of disability in developed countries across the world. Schizophrenia can also reduce a person's life expectancy by up to 18 years, according to the study and is a major cause of suicide. "Up to half of schizophrenia patients attempt suicide and five percent die by suicide." (For more information on the Wollongong study, click here.)
In New Zealand, the Ministry of Health officials in New Zealand announced that CBD products will no longer require individual approval from the agency for use, allowing it to be prescribed by physicians much like any other prescription drug, according to a local health news report. The changes are scheduled to take effect sometime in August 2017.
So how likely is it CBDs will become the norm over "Big Pharma's" deadly prescription meds? Very likely.
The Hemp University has been established to be the blueprint for farming, navigating and thriving in the industrial hemp revolution. With the goal to educate its attendees on key topics such as transitioning from traditional farming to organic farming, different hemp cultivar strains, how and where to get certified seeds, planting and harvesting industrial hemp, an in depth history of hemp and its many uses, agronomy, permaculture, ecological advantages and many more courses with an ever expanding curriculum. Hemp, Inc. (OTC PINK: HEMP) has secured an outstanding lineup of experts from at least a dozen states all over the country, including New York, Virginia, North Carolina, South Carolina, Nevada, Colorado, Oregon, Kentucky, Illinois and more for the 2017 season.
Classes will also cover such topics as organic certification, potential licensing fees, what's happening with industrial hemp in different states around America, high CBD strains and different CBD extraction technologies (which will also be installed and showcased at Hemp, Inc.'s processing facility) and marketability of the crop. The seminars started in March, this year, with the 3rd one scheduled for June 24, 2017, The Art and Science of CBD Greenhouse Growing.
Hemp retail products from all around the country will be showcased at The Hemp University. Attendees will also be able to connect with potential industrial hemp distributors and product manufacturers. Our new "Hemp Hub" will be a one stop shop for every aspect of industrial hemp from seed and soil to sale. Providing as many resources as possible to our American farmers and land owners to successfully grow hemp and have sales channels for the potential 25,000 products our hemp industry can produce.
For those interested in attending, teaching, touring the hemp field and hemp processing facility or showcasing your company's hemp products, at The Hemp University, contact Rick Rainbolt via phone or text at (704) 965-8935 for additional information.
ABOUT THE "HEMP GROWING, CBD PRODUCING VETERAN VILLAGE KINS COMMUNITIES"
Aligned with Hemp, Inc.'s Triple Bottom Line approach, CEO Bruce Perlowin is exploring the possibilities of developing "Hemp Growing, CBD Producing Veteran Village Kins Communities" in North Carolina, Florida, Kentucky and several other states similar to the 500-acre demonstration community being built in Arizona. He currently has 4,500 acres (and counting) of land north of Kingman, Arizona where he's building a Veteran Village on 500 of those acres that would consist of 160 lots of 2 1/2 acre parcels for Kins Domains (eco-villages). Each parcel would grow 1 acre of hemp as well as having organic gardens, natural beehives, a pond, a living fence and other elements that make up a Kins Domain.
